Leonard Schleifer
Chief Executive Officer at REGENERON PHARMACEUTICALS, INC.
Net worth: 2 340 M $ as of 2024-02-28
Profile
Founder of Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer is Co-President, Chief Executive Officer & Director at this company. He previously was Assistant Professor at Weill Cornell Medical College. Dr. Schleifer received a doctorate from the University of Virginia.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-04-10 | 1,726,565 ( 82.61% ) | 1 668 M $ | 2024-02-28 | |
2023-12-10 | 695,330 ( 0.64% ) | 672 M $ | 2024-02-28 |
Leonard Schleifer active positions
Companies | Position | Start |
---|---|---|
REGENERON PHARMACEUTICALS, INC. | Chief Executive Officer | 1988-01-07 |
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Chief Executive Officer | 2012-12-31 |
Former positions of Leonard Schleifer
Companies | Position | End |
---|---|---|
Weill Cornell Medical College | Corporate Officer/Principal | - |
Training of Leonard Schleifer
University of Virginia | Doctorate Degree |
Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
REGENERON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Health Technology |